Medical Coatings Market by Coating Type (Active, Passive), Material Type (Polymers, Metals), Application (Medical Devices, Medical Implants, Medical Equipment & Tools, Protective Clothing), and Region - Global Forecast to 2025
[192 Pages Report] The global medical coatings market size is projected to grow from USD 6.0 billion in 2020 to USD 15.2 billion by 2025, at a CAGR of 20.5% during the forecast period. The growth of this market can be attributed to the rising income levels in emerging economies, a growing percentage of the geriatric population, and the increasing use of home healthcare facilities. Also, the increasing demand for minimally invasive surgical procedures is also anticipated to drive the growth of the medical coatings market.
To know about the assumptions considered Request for Free Sample Report
COVID-19 Impact on Medical Coatings Market
The medical coatings market includes major Tier I and II manufacturers like DSM, Hydromer, Surmodics, Biocoat and AST Products. These suppliers have their manufacturing facilities spread across various countries across Asia Pacific, Europe, North America, South America, and Middle East & Africa. COVID-19 has impacted their businesses as well.
- In April 2020, Hydromer partnered with N8 Medical for the supply of coatings to manufacture CeraShield endotracheal tubes. These tubes play a crucial role in the treatment of COVID-19 patients. This development exhibits active involvement of the company in the coatings market.
The COVID-19 pandemic is spreading rapidly. 15,236,977 positive cases have been registered as of mid-July, 2020. The European Commission recently adopted a proposal on April 3, 2020, to postpone the application date of Medical Devices Regulation (MDR) for one year. The European Commission has recently approved revised harmonized standards to expedite the production of medical face masks, gloves, containers for intravenous injections, and sterilization devices and disinfectants, and alter particular requirements for emergency and transport ventilators. FDA has also issued Emergency Use Authorizations (EUA) for medical devices, including IVD test kits to diagnose COVID-19 and PPE (gloves, gowns, and masks) needed to protect healthcare providers interacting with patients.
Medical Coatings Market Dynamics
Driver: Increasing use of minimally invasive surgical procedures
In a minimally invasive surgery, doctors use a variety of techniques to operate with less damage to the body than with open surgery. Minimally invasive surgery is associated with less pain, a shorter hospital stay, and fewer complications. This type of surgery offers many benefits compared to traditional open surgery techniques. In many cases, it also offers a higher accuracy rate compared to traditional open surgery. The importance of less invasive medical procedures over conventional surgical procedures is increasing. The increasing prevalence of arthritis, cancer, and cardiovascular diseases, which require complex surgical treatment, has increased the demand for minimally invasive procedures. This has boosted the consumption of lightweight medical devices, such as intravascular catheters, guidewires, balloon angioplasty catheters, delivery sheaths, and implant delivery systems that can navigate through complex and sensitive parts of the body. These devices are commonly used during minimally invasive procedures in cerebrovascular, cardiovascular, and peripheral vascular systems. They often have hydrophilic and hydrophobic coatings for easy insertion of such devices into narrow vascular areas with a reduction in tissue damage. Thus, medical coatings play a major role in promoting cost efficiency and less time consumption and are highly preferred in these medical procedures. For instance, use of coatings on medical devices for cardiac and urinary catheterization procedures significantly reduces the time taken for the concerned medical or surgical procedure.
Restraint: High upfront costs and increasing raw material prices
Medical coatings manufacturing entails huge up-front and continuing costs. There are many old or expired patents in this field, and medical coating developers are not allowed to develop new coatings based on past patents to avoid royalty. Hence, up-front payments are required to access expired technology. This factor is restraining the growth of this market. Eliminating all of the up-front costs and hassles is expected to enable the explosion of technology improvements. Formulation of new medical coatings involves legal wrangling, signing nondisclosure agreements, and other expenses. The rising cost of raw materials, such as silicone rubber and PTFE, are also inhibiting the medical coatings market growth to some extent.
Opportunity: Complex design of medical devices demanding atomic layer deposition
The scope of applications of medical coatings is quite high, owing to their functional properties. There is an increasing focus on the advancements of medical devices used in treatment, mitigation, diagnosis, and prevention of diseases and abnormal physical conditions. The medical technology sector experiences continuous evolution; major focus areas are innovative imaging devices and systems, minimally invasive therapeutic products, combination device and drug/biological products, computerized devices and medical IT systems, home- and self-care products, patient monitoring systems, and artificial organs and organ-assistive products. Innovation instruments range from simple surgical instruments, such as tongue depressors and bedpans, to complex programmable pacemakers with microchip technology and laser surgical devices. Rising complexity of medical devices has led to the use of a variety of materials to manufacture these devices. However, materials used to manufacture these devices are not necessarily biocompatible and hemocompatible. To provide the desired properties to the devices, the demand for medical coatings is expected to increase. Coatings can be required to cover the entire complex structure or just part of the complex structure, and it is required to adhere to a variety of materials used within a device. Market players are developing surface treatment methods and techniques to keep up with improvements to existing substrates, as well as newly developed substrates and polymers.
The complex nature of medical devices necessitates atomic layer deposition of a coating to form a uniform layer in the targeted area of a device. Advancements in medical device designing also require the use of nanotechnology that enables deposition of multiple coating layers and helps in eliminating defects and enhance biocompatibility. Continuous developments in medical technology present an opportunity for medical coating manufacturers to develop the best solutions for critical end-use requirements.
Challenge:Stringent and time-consuming regulatory approval process
All medical devices need to undergo design verification tests to demonstrate if they meet the specifications and, therefore, require time for approval. Regulatory bodies do not approve coatings separately. Medical OEMs have different coating materials and methodology options to choose for medical devices. The involvement of the coating supplier in the early stage of product development cycle is extremely beneficial to OEMs and can positively affect the development speed, efficiency, and cost. The coated device needs to be approved or cleared by regulatory bodies. However, some coating manufacturers perform tests on their coatings to maintain high quality. Major coating manufacturers in the market also maintain a Master File with the FDA, which shows all proprietary ingredients and processes involved with the product. A device manufacturer can incorporate this by referring to their regulatory submissions. This may save time for device development. However, the regulatory approval process remains time-consuming. The approval time varies largely according to device types. On average, the FDA takes more than three months to approve a medical device. Many coating manufacturers provide regulatory services to their customers, under which they may provide regulatory filing support and coating design requirement verification and validation process. Changes in regulations can affect medical device manufacturers as well as medical coating manufacturers. FDA regulations are likely to become more complicated and expensive in the future.
Passive coatings to be the largest coating type segment
The passive coatings segment accounts for the largest share of the overall market. Hydrophilic coatings are widely used on guidewires, catheters, and introducer sheaths to lower friction coefficient. These coatings have properties such as lubricity, durability, low friction coefficient, and low particulate count. Hydrophobic coatings are water- or fluid-repellent and hence suitable for medical equipment. Minimal invasion and easy insertion of medical devices in biological openings offered by the hydrophilic coatings and excellent water repellent properties exhibited by the hydrophobic coatings are responsible for the large market size of passive medial coatings.
Polymers to be the fastest-growing material type segment
Polymer-based medical coatings are used in medical devices, medical equipment & tools, protective clothing, and medical implants. They are necessary to optimize durability and corrosion resistance while minimizing the coefficient of friction. Major subtypes of polymer coatings used on medical devices, medical implants, and other applications are fluoropolymers, silicone, parylene, and polyurethanes. Easy availability, low cost, optimum performance, multifunctionality, and low particulate technology are boosting the polymer-based medical coatings market.
Medical devices to be the fastest-growing application segment
The medical coatings market is segmented based on application into medical devices, medical implants, medical equipment & tools, protective clothing, and others. The medical devices segment accounted for the largest market share in 2019. Increased use of medical devices in the emerging economies, such as China and India, has led to the high growth of the market. The pandemic has further increased the demand for medical devices, such as catheters, guidewires, endotracheal tubes, positive pressure breathing devices, in-vitro diagnostic devices, cannulas, ventilators, ventilator accessories, infusion pumps, respirators, and other devices.
North America to account for the largest market share
North America accounted for the largest share of the medical coatings market in 2019. Increased spending in the healthcare industry is driving the market for medical coatings in the region. The US was the largest medical coatings market in the region in 2019. Growing exports of medical devices, along with advancements in medical technology and increasing demand for home healthcare, are fueling the market in the region.
To know about the assumptions considered for the study, download the pdf brochure
Key Market Players
The medical coatings market comprises major players such DSM (Netherlands), Hydromer (US), Surmodics (US), Biocoat (US), and AST Products (US). Hydomer is among the leading medical coatings manufacturers globally. New product launch and investment & expansion were the key strategies adopted by the company to penetrate the global medical coatings market.
Scope of the Report:
|
Report Metric |
Details |
|
Years Considered for the study |
2018-2025 |
|
Base year |
2019 |
|
Forecast period |
2020-2025 |
|
Units considered |
Volume (Kiloton and Ton) |
|
Segments |
Coating Type, Material Type, Application, and Region |
|
Regions |
North America, APAC, Europe, South America, and Middle East & Africa |
|
Companies |
DSM (Netherlands), Hydromer (US), Surmodics (US), Biocoat (US), AST Products (US), Total 25 major players covered |
This research report categorizes the medical coatings market based on type, application, and region.
Based on coating type:
- Active coatings
- Passive coatings
Based on material type:
- Polymers
- Metals
- Others
Based on the application:
- Medical Devices
- Medical Implants
- Medical Equipment & Tools
- Protective Clothing
- Others
Based on the region:
- APAC
- Europe
- North America
- South America
- Middle East & Africa
Recent Developments
- In 2020, Hydromer partnered with N8 Medical for the supply of coatings to manufacture CeraShield endotracheal tubes. These tubes play a crucial role in the treatment of COVID-19 patients. This development exhibits active involvement of the company in the coatings market.
- In 2018, Abbott and Surmodics entered into an agreement, under which, Abbott will have exclusive worldwide commercialization rights for Surmodics' SurVeil drug-coated balloons. These balloons are under the US pivotal clinical trial to treat superficial femoral artery.
- In 2020, Biocoat launched of HYDAK UV. The new version of its original HYDAK coating is cured using ultraviolet (UV) light. This coating allows for flexible integration with industry-standard UV coating systems. This development has expanded the company’s product portfolio
- In 2016, DSM Biomedical partnered with Vention Medical, a global integrated solutions partner. The partnership offers integration of development, testing, and application of DSM’s ComfortCoat coating into the catheter manufacturing process. This development eliminates the need to transfer finished products to another supplier for development and coating application services.
Frequently Asked Questions (FAQ):
What is the current size of the global medical coatings market?
The global medical coatings market is estimated to be USD 6.0 billion in 2020 and projected to reach USD 15.2 billion by 2025, at a CAGR of 20.5%.
What are some of the regulatory authorities controlling medical coatings market?
Different countries have introduced regulations that mandate bicomapatibility and other functionalities fo medical devices.The regulatory authorities include Australian Therapeutic Goods Administration (TGA) (Australia), Health Canada (Canada), China Food and Drug Administration (China), The National Agency for the Safety of Medicines and Health Products (ANSM) (France), Federal Institute for Drugs and medical Devices (BfArM) (Germany), Medicines & Healthcare products Regulatory Agency (MHRA) (UK), US Center for Devices and Radiological Health (CDRH) (US), Food and Drugs Administration (FDA).
Who are the winners in the global medical coatings market?
Companies such as Hydromer, DSM, Surmodics, Biocoat, and AST Products fall under the winners cegory. These companies cater to the requirements of their customers by providing customized products. Moreover, these companies have multiple supply contracts with global medical device manufacturers and have effective supply chain strategies.
What is the COVID-19 impact on medical coatings manufacturers?
Industry experts believe that COVID-19 could have positive impact on medical coatings production by 15–20% globally in 2020. For instance, In April 2020, Hydromer partnered with N8 Medical for the supply of coatings to manufacture CeraShield endotracheal tubes. These tubes play a crucial role in the treatment of COVID-19 patients. This development exhibits active involvement of the company in the coatings market. The European Commission has recently approved revised harmonized standards to expedite the production of medical face masks, gloves, containers for intravenous injections, and sterilization devices and disinfectants, and alter particular requirements for emergency and transport ventilators. FDA has also issued Emergency Use Authorizations (EUA) for medical devices, including IVD test kits to diagnose COVID-19.
What are some of the technological advancements in the market?
Various research activities have been conducted by medical device manufacturers and medical coatings manufacturers across the globe to enhance passive safety systems. Companies are focused on use of nanotechnology to achieve low particulate generation and enhanced biocompatibility. For instance, Harland Medical Systems launched Lubricent Ultra Hydrophilic Coating Solution that provides superior adhesion, low particulate generation, and excellent lubricity. This product launch helped the company to offer high durability and superior lubricity coating suitable for various applications. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 25)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MEDICAL COATINGS MARKET SEGMENTATION
1.3.2 REGIONS COVERED
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 UNIT CONSIDERED
1.6 STAKEHOLDERS
1.7 LIMITATIONS
1.8 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 30)
2.1 RESEARCH DATA
FIGURE 1 MEDICAL COATINGS MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.1.2.3 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
FIGURE 2 MEDICAL COATINGS MARKET: BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
FIGURE 3 MEDICAL COATINGS MARKET: TOP-DOWN APPROACH
2.3 DATA TRIANGULATION
FIGURE 4 MEDICAL COATINGS MARKET: DATA TRIANGULATION
2.3.1 MEDICAL COATINGS MARKET ANALYSIS THROUGH PRIMARY INTERVIEWS
FIGURE 5 MEDICAL COATINGS MARKET ANALYSIS THROUGH SECONDARY SOURCES
FIGURE 6 MEDICAL COATINGS MARKET ANALYSIS
2.4 LIMITATIONS
2.5 ASSUMPTIONS
3 EXECUTIVE SUMMARY (Page No. - 39)
FIGURE 7 PASSIVE COATINGS SEGMENT TO LEAD THE MARKET
FIGURE 8 POLYMERS TO BE THE LEADING MATERIAL TYPE OF MEDICAL COATINGS
FIGURE 9 MEDICAL DEVICES SEGMENT WAS LARGEST APPLICATION OF MEDICAL COATINGS IN 2019
FIGURE 10 NORTH AMERICA WAS THE LARGEST MEDICAL COATINGS MARKET IN 2019
4 PREMIUM INSIGHTS (Page No. - 43)
4.1 ATTRACTIVE OPPORTUNITIES IN MEDICAL COATINGS MARKET
FIGURE 11 GROWTH OF MEDICAL DEVICE SECTOR TO DRIVE MEDICAL COATINGS MARKET
4.2 MEDICAL COATINGS MARKET SIZE, BY COATING TYPE
FIGURE 12 PASSIVE COATINGS TO DOMINATE THE MARKET
FIGURE 13 POLYMERS SEGMENT TO DOMINATE MEDICAL COATINGS MARKET
4.3 MEDICAL COATINGS MARKET, BY APPLICATION
FIGURE 14 MEDICAL DEVICES TO BE THE LARGEST SEGMENT
4.4 NORTH AMERICA: MEDICAL COATINGS MARKET, BY APPLICATION AND COUNTRY, 2019
FIGURE 15 US AND MEDICAL DEVICES SEGMENT ACCOUNTED FOR LARGEST SHARES
4.5 MEDICAL COATINGS MARKET, BY MAJOR COUNTRIES
FIGURE 16 INDIA TO REGISTER HIGHEST CAGR BETWEEN 2020 AND 2025
5 MARKET OVERVIEW (Page No. - 46)
5.1 MARKET DYNAMICS
FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN MEDICAL COATINGS MARKET
5.1.1 DRIVERS
5.1.1.1 Growth in population, income levels, and health awareness
FIGURE 18 INCREASING GERIATRIC POPULATION TO DRIVE MEDICAL COATINGS MARKET
FIGURE 19 GROWING GDP TO INCREASE HEALTHCARE INVESTMENTS
5.1.1.2 Increasing use of minimally invasive surgical procedures
5.1.1.3 Rising demand for home healthcare
5.1.1.4 Rapid spread of COVID-19 and high risk of HAIs
5.1.2 RESTRAINTS
5.1.2.1 High upfront costs and increasing raw material prices
5.1.2.2 Low shelf life of coatings
5.1.3 OPPORTUNITIES
5.1.3.1 Emergence of nanotechnology and growing market for multifunctional coatings
5.1.3.2 Complex design of medical devices demanding atomic layer deposition
5.1.4 CHALLENGES
5.1.4.1 Stringent and time-consuming regulatory approval process
5.1.4.2 Variations in regulations across countries
5.2 TECHNOLOGY ANALYSIS
5.3 TARIFFS AND REGULATIONS
5.4 COVID-19 IMPACT
5.5 AVERAGE SELLING PRICE ANALYSIS
5.6 CASE STUDY ANALYSIS
5.7 VALUE CHAIN ANALYSIS
FIGURE 20 OVERVIEW OF MEDICAL COATINGS VALUE CHAIN
5.7.1 RAW MATERIAL SUPPLIERS
5.7.2 MANUFACTURERS
5.7.3 DEVICE MANUFACTURERS
5.7.4 CONTRACT MANUFACTURERS
5.7.5 VALUE ADDITION
5.7.6 REGULATORY BODIES
5.7.7 INDUSTRIAL AND INSTITUTIONAL R&D
5.7.8 HEALTHCARE PROVIDERS
5.8 PORTER’S FIVE FORCES ANALYSIS
FIGURE 21 PORTER’S FIVE FORCES ANALYSIS OF MEDICAL COATINGS MARKET
5.8.1 BARGAINING POWER OF SUPPLIERS
5.8.2 BARGAINING POWER OF BUYERS
5.8.3 THREAT OF SUBSTITUTES
5.8.4 THREAT OF NEW ENTRANTS
5.8.5 INTENSITY OF RIVALRY
6 MEDICAL COATINGS MARKET, BY TYPE (Page No. - 62)
6.1 INTRODUCTION
6.2 MEDICAL COATINGS MARKET, BY COATING TYPE
FIGURE 22 PASSIVE COATINGS TO ACCOUNT FOR LARGER MARKET SHARE
TABLE 1 MEDICAL COATINGS MARKET SIZE, BY COATING TYPE, 2018–2025 (KILOTON)
TABLE 2 MEDICAL COATINGS MARKET SIZE , BY COATING TYPE, 2018–2025 (USD MILLION)
6.2.1 ACTIVE COATINGS
TABLE 3 MEDICAL COATINGS MARKET SIZE, BY ACTIVE COATING TYPE, 2018–2025 (KILOTON)
TABLE 4 MEDICAL COATINGS MARKET SIZE, BY ACTIVE COATING TYPE, 2018–2025 (USD MILLION)
6.2.1.1 Antimicrobial coatings
6.2.1.1.1 Used to prevent microbial infection on medical devices
6.2.1.2 Others
6.2.1.2.1 Antithrombogenic coatings
6.2.1.2.2 Drug-eluting coatings
6.2.1.2.3 Anti-fog coatings
6.2.2 PASSIVE COATINGS
TABLE 5 MEDICAL COATINGS MARKET SIZE, BY PASSIVE COATING TYPE, 2018–2025 (KILOTON)
TABLE 6 MEDICAL COATINGS MARKET SIZE, BY PASSIVE COATING TYPE, 2018–2025 (USD MILLION)
6.2.2.1 Hydrophilic coatings/lubricious hydrophilic coatings
6.2.2.1.1 Increasing awareness of minimally invasive procedures to drive the demand for hydrophilic medical coatings
6.2.2.2 Hydrophobic coatings
6.2.2.2.1 Excellent water resistance of these coatings to fuel the market
6.3 MEDICAL COATINGS MARKET, BY MATERIAL TYPE
FIGURE 23 POLYMERS TO ACCOUNT FOR LARGEST MARKET SHARE
TABLE 7 MEDICAL COATINGS MARKET SIZE , BY MATERIAL TYPE, 2018–2025 (KILOTON)
TABLE 8 MEDICAL COATINGS MARKET SIZE, BY MATERIAL TYPE, 2018–2025 (USD MILLION)
6.3.1 POLYMERS
6.3.1.1 Fluoropolymers
6.3.1.1.1 PTFE
6.3.1.1.1.1 Has low friction release and resistance to heat and chemicals
6.3.1.1.2 PVDF
6.3.1.1.2.1 Highly durable and chemical-resistant
6.3.1.1.3 Others
6.3.1.2 Parylene
6.3.1.2.1 Transparent with a coefficient of friction similar to PTFE
6.3.1.3 Silicones
6.3.1.3.1 Biocompatibility of silicones to drive their use in medical applications
6.3.1.4 Others
6.3.2 METALS
6.3.2.1 Silver
6.3.2.1.1 Used as an antimicrobial coating
6.3.2.2 Titanium
6.3.2.2.1 Generally used in implant applications due to its biocompatibility
6.3.2.3 Others
6.3.3 OTHERS
7 MEDICAL COATINGS MARKET, BY SUBSTRATE TYPE (Page No. - 73)
7.1 INTRODUCTION
7.2 MEDICAL COATINGS, BY SUBSTRATE TYPE
7.2.1 METALS
7.2.1.1 Titanium
7.2.1.2 Stainless steel
7.2.1.3 Others
7.2.2 CERAMICS
7.2.3 POLYMERS
7.2.3.1 Fluoropolymers
7.2.3.2 Silicone
7.2.3.3 Other polymers
7.2.4 COMPOSITES
7.2.5 GLASS
8 MEDICAL COATINGS MARKET, BY APPLICATION (Page No. - 76)
8.1 INTRODUCTION
FIGURE 24 MEDICAL DEVICES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE
TABLE 9 MEDICAL COATINGS MARKET, BY APPLICATION, 2018–2025 ( KILOTON)
TABLE 10 MEDICAL COATINGS MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
8.2 MEDICAL DEVICES
8.2.1 INCREASING DEMAND FOR MINIMALLY INVASIVE SURGICAL PROCEDURES TO BOOST THE MARKET
8.3 MEDICAL IMPLANTS
8.3.1 ORTHOPEDIC IMPLANTS
8.3.1.1 Coatings offer lubricity and fatigue strength to orthopedic implants
8.3.2 DENTAL IMPLANTS
8.3.2.1 Dental implants coated with hydroxyapatite (HAP) stimulate bone healing
8.3.3 CARDIOVASCULAR IMPLANTS
8.3.3.1 Nanomaterial coatings are used for stents
8.4 MEDICAL EQUIPMENT & TOOLS
8.4.1 SURGICAL EQUIPMENT & TOOLS
8.4.1.1 Coatings offer antimicrobial and other functional properties to surgical tools
8.4.2 INSTITUTIONAL EQUIPMENT
8.4.2.1 Hydrophobic coatings are used for this equipment
8.5 PROTECTIVE CLOTHING
8.5.1 RAPID SPREAD OF COVID-19 DRIVING THE CONSUMPTION OF PROTECTIVE CLOTHING
8.6 OTHERS
9 MEDICAL COATINGS MARKET, BY REGION (Page No. - 82)
9.1 INTRODUCTION
FIGURE 25 MEDICAL COATINGS MARKET IN INDIA TO REGISTER THE HOGHEST CAGR
TABLE 11 MEDICAL COATINGS MARKET SIZE, BY REGION, 2018–2025 (KILOTON)
TABLE 12 MEDICAL COATINGS MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 26 NORTH AMERICA: MEDICAL COATINGS MARKET SNAPSHOT
TABLE 13 NORTH AMERICA: MEDICAL COATINGS MARKET SIZE, BY COUNTRY, 2018–2025 (KILOTON)
TABLE 14 NORTH AMERICA: MEDICAL COATINGS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 15 NORTH AMERICA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (KILOTON)
TABLE 16 NORTH AMERICA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
9.2.1 US
9.2.1.1 Advancements in medical technology to propel the market
TABLE 17 US: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (KILOTON)
TABLE 18 US: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Rising exports to boost the demand for medical coatings
TABLE 19 CANADA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (KILOTON)
TABLE 20 CANADA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
9.2.3 MEXICO
9.2.3.1 Growth in domestic production activities to drive the market
TABLE 21 MEXICO: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (KILOTON)
TABLE 22 MEXICO: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
9.3 EUROPE
FIGURE 27 EUROPE: MEDICAL COATINGS MARKET SNAPSHOT
TABLE 23 EUROPE: MEDICAL COATINGS MARKET SIZE, BY COUNTRY, 2018–2025 (KILOTON)
TABLE 24 EUROPE: MEDICAL COATINGS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 25 EUROPE: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (KILOTON)
TABLE 26 EUROPE: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Innovations in medical technology to drive the market
TABLE 27 GERMANY: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (KILOTON)
TABLE 28 GERMANY: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
9.3.2 FRANCE
9.3.2.1 Presence of a well-established medical device manufacturing industry to boost the market
TABLE 29 FRANCE: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (KILOTON)
TABLE 30 FRANCE: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
9.3.3 UK
9.3.3.1 Government initiatives for collaborative developments in medical technology to drive the market
TABLE 31 UK: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (KILOTON)
TABLE 32 UK: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Fourth-largest medical technology market in Europe
TABLE 33 ITALY: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (TON)
TABLE 34 ITALY: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
9.3.5 RUSSIA
9.3.5.1 Rising demand for minimally invasive procedures to spur the market
TABLE 35 RUSSIA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (TON)
TABLE 36 RUSSIA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
9.3.6 SPAIN
9.3.6.1 Among the largest consumers of medical coatings in the region
TABLE 37 SPAIN: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (TON)
TABLE 38 SPAIN: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
9.3.7 REST OF EUROPE
TABLE 39 REST OF EUROPE: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (TON)
TABLE 40 REST OF EUROPE: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
9.4 APAC
FIGURE 28 APAC: MEDICAL COATINGS MARKET SNAPSHOT
TABLE 41 APAC: MEDICAL COATINGS MARKET SIZE, BY COUNTRY, 2018–2025 (KILOTON)
TABLE 42 APAC: MEDICAL COATINGS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 43 APAC: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (KILOTON)
TABLE 44 APAC: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
9.4.1 CHINA
9.4.1.1 Third-largest medical device manufacturing market globally
TABLE 45 CHINA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (KILOTON)
TABLE 46 CHINA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Increasing percentage of geriatric population to drive the market
TABLE 47 JAPAN: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (KILOTON)
TABLE 48 JAPAN: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
9.4.3 SOUTH KOREA
9.4.3.1 Continuous R&D activities to fuel the medical device market
TABLE 49 SOUTH KOREA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (TON)
TABLE 50 SOUTH KOREA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
9.4.4 INDIA
9.4.4.1 Creation of medical device cluster projects to enhance the demand for medical coatings
TABLE 51 INDIA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (TON)
TABLE 52 INDIA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
9.4.5 AUSTRALIA
9.4.5.1 Increased life expectancy to indirectly fuel the demand for medical devices
TABLE 53 AUSTRALIA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (TON)
TABLE 54 AUSTRALIA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
9.4.6 REST OF APAC
TABLE 55 REST OF APAC: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (TON)
TABLE 56 REST OF APAC: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
9.5 SOUTH AMERICA
TABLE 57 SOUTH AMERICA: MEDICAL COATINGS MARKET SIZE, BY COUNTRY, 2018–2025 (KILOTON)
TABLE 58 SOUTH AMERICA: MEDICAL COATINGS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 59 SOUTH AMERICA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (KILOTON)
TABLE 60 SOUTH AMERICA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 Increasing domestic production of medical devices to drive the market
TABLE 61 BRAZIL: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (KILOTON)
TABLE 62 BRAZIL: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
9.5.2 ARGENTINA
9.5.2.1 Increasing risk of non-communicable diseases to boost the demand
TABLE 63 ARGENTINA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (TON)
TABLE 64 ARGENTINA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
9.5.3 REST OF SOUTH AMERICA
TABLE 65 REST OF SOUTH AMERICA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (TON)
TABLE 66 REST OF SOUTH AMERICA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
9.6 MIDDLE EAST AND AFRICA
TABLE 67 MIDDLE EAST & AFRICA: MEDICAL COATINGS MARKET SIZE, BY COUNTRY, 2018–2025 (KILOTON)
TABLE 68 MIDDLE EAST & AFRICA: MEDICAL COATINGS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 69 MIDDLE EAST & AFRICA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (KILOTON)
TABLE 70 MIDDLE EAST & AFRICA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
9.6.1 SAUDI ARABIA
9.6.1.1 Government initiatives for healthcare industry to drive the market
TABLE 71 SAUDI ARABIA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (TON)
TABLE 72 SAUDI ARABIA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
9.6.2 SOUTH AFRICA
9.6.2.1 Investments by global medical device companies to drive the medical coatings market
TABLE 73 SOUTH AFRICA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (TON)
TABLE 74 SOUTH AFRICA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
9.6.3 UAE
9.6.3.1 Diversification of economy to propel the demand for medical coatings
TABLE 75 UAE: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (TON)
TABLE 76 UAE: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
9.6.4 REST OF MIDDLE EAST & AFRICA
TABLE 77 REST OF MIDDLE EAST & AFRICA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (TON)
TABLE 78 REST OF MIDDLE EAST & AFRICA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 120)
10.1 OVERVIEW
FIGURE 29 COMPANIES ADOPTED INVESTMENT & EXPANSION AS THE KEY GROWTH STRATEGY BETWEEN 2016 AND 2020
10.2 COMPETITIVE LEADERSHIP MAPPING, 2019
10.2.1 VISIONARY LEADERS
10.2.2 INNOVATORS
10.2.3 DYNAMIC DIFFERENTIATORS
10.2.4 EMERGING COMPANIES
FIGURE 30 MEDICAL COATINGS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019
10.3 COMPETITIVE BENCHMARKING
FIGURE 31 PRODUCT PORTFOLIO ANALYSIS OF TOP PLAYERS IN MEDICAL COATINGS MARKET
10.3.1 BUSINESS STRATEGY EXCELLENCE
FIGURE 32 BUSINESS STRATEGY EXCELLENCE OF TOP PLAYERS IN MEDICAL COATINGS MARKET
10.4 MARKET RANKING OF KEY PLAYERS
10.5 MARKET SHARE ANALYSIS
10.6 COMPETITIVE SITUATION & TRENDS
10.6.1 PARTNERSHIP
TABLE 79 PARTNERSHIP (2016–2020)
10.6.2 NEW PRODUCT DEVELOPMENT
TABLE 80 NEW PRODUCT DEVELOPMENT (2016–2020)
10.6.3 MERGER & ACQUISITION
TABLE 81 MERGER & AQUISITION (2016–2020)
10.6.4 AGREEMENT & COLLABORATION
TABLE 82 AGREEMENT & COLLABORATION (2016–2020)
10.6.5 INVESTMENT & EXPANSION
TABLE 83 INVESTMENT & EXPANSION (2016–2020)
11 COMPANY PROFILES (Page No. - 132)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
11.1 HYDROMER
FIGURE 33 HYDROMER: COMPANY SNAPSHOT
FIGURE 34 HYDROMER: SWOT ANALYSIS
11.2 DSM
FIGURE 35 DSM: COMPANY SNAPSHOT
TABLE 84 WALLET SHARE OF END-USE MARKET FOR DSM
FIGURE 36 DSM: SWOT ANALYSIS
11.3 SURMODICS
FIGURE 37 SURMODICS: COMPANY SNAPSHOT
FIGURE 38 SURMODICS: SWOT ANALYSIS
11.4 BIOCOAT
FIGURE 39 BIOCOAT INC.: SWOT ANALYSIS
11.5 AST PRODUCTS INC.
11.6 COVALON TECHNOLOGIES LTD.
11.7 FREUDENBERG MEDICAL
11.8 MERIT MEDICAL OEM
11.9 HARLAND MEDICAL SYSTEMS INC.
11.10 APPLIED MEDICAL COATINGS
11.11 OTHERS
11.11.1 APPLIED MEMBRANE TECHNOLOGIES
11.11.2 A&A COATINGS
11.11.3 CALICO COATINGS
11.11.4 COATINGS2GO
11.11.5 CURTISS WRIGHT CORPORATION
11.11.6 ENCAPSON
11.11.7 ENDURA COATINGS
11.11.8 HTI TECHNOLOGIES
11.11.9 MATERION CORPORATION
11.11.10 MEDICOAT
11.11.11 MILLER-STEPHENSON
11.11.12 PRECISION COATING TECHNOLOGY & MANUFACTURING
11.11.13 SPECIALTY COATINGS SYSTEMS
11.11.14 SURFACE TECHNOLOGY
11.11.15 WHITFORD
*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
12 ADJACENT/RELATED MARKETS (Page No. - 158)
12.1 INTRODUCTION
12.2 LIMITATION
12.3 PAINTS & COATINGS ECOSYSTEM AND INTERCONNECTED MARKET
12.4 CATHETERS
12.4.1 MARKET DEFINITION
12.4.2 MARKET OVERVIEW
12.4.3 CATHETERS MARKET, BY RESIN TYPE
TABLE 85 CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
12.4.3.1 Cardiovascular Catheters
TABLE 86 CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
12.4.3.1.1 Electrophysiology Catheters
12.4.3.1.1.1 Electrophysiology catheters dominate the cardiovascular catheters market
12.4.3.1.2 Angiography Catheters
12.4.3.1.2.1 Benefits of angiography have supported the demand for related catheters
12.4.3.1.3 Balloon Catheters
12.4.3.1.3.1 Demand for balloon catheters is expected to inflate in the APAC
12.4.3.1.4 IVUS/OCT Catheters
12.4.3.1.4.1 Penetration of market products is higher in Japan as compared to the US and Europe
12.4.3.1.5 Guiding Catheters
12.4.3.1.5.1 Rising number of interventional and angiography procedures will drive market growth
12.4.3.2 Intravenous Catheters
TABLE 87 INTRAVENOUS CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
12.4.3.2.1 Central Venous Catheters
TABLE 88 CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
12.4.3.2.2 Peripherally Inserted Central Catheters
12.4.3.2.2.1 PICCs dominate the central venous catheters market
12.4.3.2.3 Non-tunneled central catheters
12.4.3.2.3.1 Non-tunneled catheters are mainly used for short-term access
12.4.3.2.4 Skin-tunneled Central Catheters
12.4.3.2.4.1 Skin-tunneled catheters are used for long-term access and feature a low infection risk
12.4.3.2.5 Implantable Ports
12.4.3.2.5.1 High convenience and minimized risk of infection has supported the adoption of implantable ports
12.4.3.2.6 Peripheral Catheters
12.4.3.2.6.1 Large usage of these devices is the key driver of market growth
12.4.3.2.7 Midline Peripheral Catheters
12.4.3.2.7.1 The use of midline peripheral catheters has declined in recent years
12.4.3.3 Urological Catheters
TABLE 89 UROLOGICAL CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
12.4.3.3.1 Urinary Catheters
TABLE 90 URINARY CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 91 URINARY CATHETERS MARKET, BY TYPE, 2018–2025 (MILLION UNITS)
12.4.3.3.2 Indwelling/Foley Catheters
12.4.3.3.2.1 Indwelling/Foley catheters dominate the urinary catheters market
12.4.3.3.3 Intermittent Catheters
12.4.3.3.3.1 Intermittent catheters will grow at the highest CAGR during the forecast period
12.4.3.3.4 External Catheters
12.4.3.3.4.1 Minimized risk of damage to the urethra and infections drive the market for external catheters
12.4.3.4 Dialysis Catheters
TABLE 92 DIALYSIS CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
12.4.3.4.1 Peritoneal Dialysis Catheters
12.4.3.4.1.1 Development of new approaches for PD catheter placement is driving their adoption
12.4.3.4.2 Hemodialysis Catheters
12.4.3.4.2.1 Hemodialysis catheters can be used for the long-term if fistulas and grafts are unsuccessful
12.4.3.5 Specialty Catheters
TABLE 93 SPECIALTY CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
12.4.3.5.1 Pressure & Hemodynamic Monitoring Catheters
12.4.3.5.1.1 Benefits such as continuous monitoring capabilities and a wide range of applications are driving segmental growth
12.4.3.5.2 Temperature Monitoring Catheters
12.4.3.5.2.1 Accuracy and need for vital sign monitoring have driven demand for temperature monitoring catheters
12.4.3.5.3 Intrauterine Insemination Catheters
12.4.3.5.3.1 IUI catheters are commonly used in infertility cases and for sonohysterography
12.4.3.5.4 Other Specialty Catheters
12.4.3.6 Neurovascular Catheters
12.4.3.6.1 Rising incidence of neurological disorders is driving the market for neurovascular catheters
12.4.4 CATHETERS MARKET, BY END USER
TABLE 94 CATHETERS MARKET, BY END USER, 2018–2025 (USD MILLION)
12.4.4.1 Hospitals
12.4.4.1.1 High patient inflow and procedural volumes make hospitals the largest end users of catheters
12.4.4.2 Long-term care facilities
12.4.4.2.1 Growing demand for long-term care supports the growth of this end-user segment
12.4.4.3 Diagnostic Imaging centers
12.4.4.3.1 Efficiency, convenience, and affordability of imaging centers drive the growth of this end-user segment
12.4.4.4 Other end users
12.4.5 CATHETERS MARKET, BY REGION
TABLE 95 CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
12.4.5.1 North America
12.4.5.2 Europe
12.4.5.3 APAC
12.4.5.4 ROW
12.5 ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET
12.5.1 MARKET DEFINITION
12.5.2 MARKET OVERVIEW
12.5.3 ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET, BY PRODUCT TYPE
TABLE 96 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
12.5.3.1 Implantable cardioverter defibrillators
TABLE 97 GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2015–2022 (USD MILLION)
12.5.3.1.1 Transvenous Implantable Cardioverter Defibrillators
TABLE 98 GLOBAL TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2015-2022 (USD MILLION)
12.5.3.1.1.1 Biventricular Implantable Cardioverter Defibrillators (ICDs)/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds)
12.5.3.1.1.2 Dual-Chamber Implantable Cardioverter Defibrillators
12.5.3.1.1.3 Single-Chamber Implantable Cardioverter Defibrillators
12.5.3.1.2 Subcutaneous Implantable Cardioverter Defibrillators
12.5.3.2 Implantable cardiac pacemakers
12.5.3.3 Ventricular assist devices
12.5.3.4 Implantable heart monitors/Insertable loop recorders
12.5.3.5 Neurostimulators
TABLE 99 NEUROSTIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2015-2022 (USD MILLION)
12.5.3.5.1 Spinal cord stimulators
12.5.3.5.2 Deep brain stimulators
12.5.3.5.3 Sacral nerve stimulators
12.5.3.5.4 Vagus nerve stimulators
12.5.3.5.5 Gastric electrical stimulators
12.5.3.5.6 Implantable hearing devices
TABLE 100 IMPLANTABLE HEARING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2015-2022 (USD MILLION)
12.5.3.5.6.1 Active hearing Implants
12.5.3.5.6.2 Passive hearing implants
12.5.4 ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET, BY REGION
TABLE 101 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
12.5.4.1 NORTH AMERICA
12.5.4.2 EUROPE
12.5.4.3 ASIA-PACIFIC
12.5.4.4 LATIN AMERICA
12.5.4.5 MIDDLE EAST AND AFRICA
13 APPENDIX (Page No. - 186)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
The study involved four major activities in estimating the current size of the medical coatings market. Exhaustive secondary research was done to collect information on the market, the peer market, and the parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.
Secondary Research
In the secondary research process, various secondary sources, such as Hoovers, Bloomberg Businessweek, Factiva, World Bank, World Health Organization’s database, United Nations Database, and Industry Journals, were referred to for identifying and collecting information for this study. These secondary sources included annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, and databases.
Primary Research
The medical coatings market comprises several stakeholders, such as raw material suppliers, processors, end-product manufacturers, and regulatory organizations in the supply chain. The supply side of this market includes lab technicians, technologists, and sales managers from the medical coatings industry. On the other hand, the demand side is characterized by advancements in technology and diverse application segments. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.
Following is the breakdown of primary respondents
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the total size of the medical coatings market. These methods were also used extensively to determine the size of various sub-segments in the market. The research methodology used to estimate the market size included the following:
- The key players in the industry and markets were identified through extensive secondary research.
- Market sizes, in terms of value and volume, were determined through primary and secondary research processes.
- All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.
Data Triangulation
After arriving at the overall market size using the medical coatings market size estimation processes explained above, the market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in various end-use industries.
Report Objectives:
- To define, describe, and forecast the medical coatings market size, in terms of value and volume
- To provide detailed information about the key factors (drivers, restraints, opportunities, and challenges) influencing the market growth
- To analyze and forecast the market by coating type, substrate type, material type, and application
- To forecast the size of the market with respect to five regions: Asia Pacific (APAC), Europe, North America, South America, and the Middle East & Africa, along with their key countries
- To strategically analyze micromarkets1 with respect to individual trends, growth prospects, and their contribution to the overall market
- To analyze the opportunities in the market for stakeholders and provide a competitive landscape for market leaders
- To strategically analyze the markets with respect to ongoing trends in various applications during the COVID-19 pandemic
- To analyze the competitive developments, such as agreement & collaboration, new product development, investment & expansion, partnership, and merger & acquisition, in the market
- To strategically profile the key players and comprehensively analyze their market shares and core competencies2
Available Customizations:
With the given market data, MarketsandMarkets offers customizations according to the company’s specific needs. The following customization options are available for the report:
Product Analysis
Product matrix, which gives a detailed comparison of the product portfolio of each company
Regional Analysis
- Further breakdown of the Rest of APAC, Rest of Europe, Rest of South America, and Rest of Middle East & Africa for medical coatings market
Company Information
- Detailed analysis and profiling of additional market players (up to five)
Get in-depth analysis of the COVID-19 impact on the Medical Coatings Market
Benchmarking the rapid strategy shifts of the Top 100 companies in the Medical Coatings Market
Request For Special Pricing
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Medical Coatings Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Medical Coatings Market
Market trends on Global Medical Coating market
Interested in coating excipient market and trends by type (film coating, enteric coating, functional coating) for India
Coating market by (hydrophilic, antimicrobial, and hemocompatible) type and by Application
General information on Medical Coatings Market